Company / Free Cash Flow per Share
Outlook Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.14
FY2020
5-year range
-$3.97 / -$0.63
FY2016-FY2020
Trend
+71.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.63 to $-1.14 over the past 2 years.
Based on SEC 10-K filings.
-1.14 in FY2020.
Declined from $-0.63 to $-1.14 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, free cash flow per share increased 71.2% year-over-year.
- Peak free cash flow per share was recorded in FY2018.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2020 | -$1.14 | +71.2% |
| FY2019 | -$3.97 | -526.3% |
| FY2018 | -$0.63 | +69.0% |
| FY2017 | -$2.04 | +46.9% |
| FY2016 | -$3.84 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026